Nantahala Capital Management, LLC
NEW CANAAN, CT · CIK 1472322 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2011 · limited liability company
- Assets managed$3.1bn
- Staff14 · 6 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 (3 hedge) · $1.3bn gross assets
- Websitenantahalapartners.com
- Form ADV · 2026-09-14SEC adviser record
- Legal entityNANTAHALA CAPITAL MANAGEMENT, LLC (US)
- Kindhedge funds, futures
- Others nearbyNew Canaan, CT
As an employer
- Offices in1 country
- Private fundshedge 3
$1.2bn
reported value
-20.2% vs Q1 2022
105positions
45.4%in top 10
11 new
29 added
50 reduced
12 sold out
vs Q1 2022
Options: 10 call positions ($127.6m notional), 9 put positions ($712.5m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ESTABLISHMENT LABS HLDGS INC ESTA | $109.2m9.46% | Reduced -141.8k |
| UNIQURE NV QURE | $57.6m4.99% | Added +279.3k |
| LIGHT & WONDER INC LNWO | $52.2m4.52% | Reduced -33.3k |
| SYNDAX PHARMACEUTICALS INC SNDX | $51.2m4.44% | Reduced -29.2k |
| IMAX CORP IMAX | $46.1m3.99% | Added +61.0k |
| MILLERKNOLL INC MLKN | $44.9m3.89% | Added +84.6k |
| TRAVELCENTERS OF AMERICA INC TA | $43.9m3.80% | Unchanged |
| CODEXIS INC CDXS | $43.1m3.73% | Added +737.0k |
| PATHWARD FINANCIAL INC CASH | $38.1m3.30% | Added +115.5k |
| TRAVEL PLUS LEISURE CO TNL | $37.9m3.28% | Added +107.8k |
| DXP ENTERPRISES INC DXPE | $36.9m3.20% | Added +15.9k |
| LUXFER HLDGS PLC LXFR | $35.2m3.05% | Added +95.4k |
| COSTCO WHSL CORP NEW COST | $34.3m2.97% | New |
| RMR GROUP INC RMR | $27.5m2.38% | Added +8.8k |
| IMMATICS N.V IMTX | $27.2m2.36% | Added +177.1k |
| KEROS THERAPEUTICS INC KROS | $25.2m2.18% | Added +95.1k |
| RED VIOLET INC RDVT | $24.6m2.13% | Added +30.5k |
| PELOTON INTERACTIVE INC PTON | $22.5m1.95% | Added +1.9m |
| DHI GROUP INC DHX | $20.6m1.78% | Added +290.7k |
| PAYA HOLDINGS INC PAYA | $19.4m1.68% | Reduced -1.2m |
| GOLDEN ENTMT INC GDEN | $19.2m1.66% | Reduced -205.6k |
| RH RH | $19.1m1.66% | New |
| MEDIAALPHA INC MAX | $16.2m1.40% | Added +1.2m |
| ALTA EQUIPMENT GROUP INC ALTG | $15.0m1.30% | Reduced -134.1k |
| AUTOLUS THERAPEUTICS PLC AUTL | $14.6m1.26% | Added +796.5k |
| APOLLO ENDOSURGERY INC COM | $13.6m1.18% | Reduced -1.9k |
| LYRA THERAPEUTICS INC LYRA | $13.4m1.16% | New |
| READING INTERNATIONAL INC RDI | $11.6m1.00% | Reduced -19.4k |
| AMRYT PHARMA PLC SPONSORED ADS | $10.9m0.95% | Added +490.9k |
| DARIOHEALTH CORP DRIO | $10.6m0.92% | Added +14.8k |
| BBQ HLDGS INC COM | $9.9m0.86% | Reduced -3.3k |
| SEMLER SCIENTIFIC INC SMLR | $9.8m0.85% | Reduced -10.3k |
| INSU ACQUISITION CORP III COM CL A | $9.7m0.84% | Reduced -15.0k |
| VIEMED HEALTHCARE INC VMD | $9.2m0.80% | Added +421.1k |
| ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS | $8.4m0.73% | Reduced -3.1k |
| RINGCENTRAL INC RNG | $7.8m0.68% | New |
| CYMABAY THERAPEUTICS INC CBAY | $7.8m0.68% | Added +750.3k |
| FTAC HERA ACQUISITION CORP CLASS A ORD SHS | $7.7m0.67% | Reduced -12.9k |
| FORTRESS BIOTECH INC COM | $7.4m0.64% | Reduced -83.9k |
| CONCERT PHARMACEUTICALS INC CNCE | $7.0m0.61% | New |
| PAR TECHNOLOGY CORP PAR 2.875 04.15.26 · principal | $6.7m0.58% | Unchanged |
| SCULLY ROYALTY LTD SRL | $6.2m0.54% | Reduced -1.2k |
| TAYSHA GENE THERAPIES INC TSHA | $6.1m0.53% | Added +309.5k |
| ARS PHARMACEUTICALS INC SPRY | $5.9m0.51% | Added +472.5k |
| ON24 INC ONTF | $5.4m0.47% | Added +186.3k |
| APTOSE BIOSCIENCES INC COM NEW | $5.4m0.47% | Reduced -89.5k |
| CATALYST BIOSCIENCES INC COM NEW | $4.9m0.43% | Added +335.1k |
| AURA BIOSCIENCES INC AURA | $4.9m0.42% | Added +41.2k |
| STRYKER CORPORATION SYK | $4.6m0.40% | New |
| STRATA SKIN SCIENCES INC SSKN | $4.4m0.38% | Unchanged |
| ISHARES TR IWM | $4.0m0.35% | Reduced -344.2k |
| CURIS INC COM NEW | $3.6m0.31% | Added +1.1m |
| INMODE LTD INMD | $3.5m0.31% | New |
| AVALO THERAPEUTICS INC COM | $3.4m0.29% | Reduced -139.2k |
| AKUMIN INC COM | $3.3m0.29% | Reduced -33.8k |
| B. RILEY FINANCIAL INC RILY | $3.3m0.28% | Reduced -1.4k |
| ARYA SCIENCES ACQU CORP IV CL A | $3.2m0.27% | Reduced -2.9k |
| B RILEY PRINCIPAL 150 MERGER COM CL A | $3.0m0.26% | Reduced -4.1k |
| RUMBLEON INC RDNW | $2.9m0.25% | New |
| PERELLA WEINBERG PARTNERS PWP | $2.9m0.25% | Unchanged |
| MERRIMACK PHARMACEUTICALS IN MACK | $2.9m0.25% | Reduced -25.3k |
| NEURONETICS INC STIM | $2.5m0.21% | Reduced -112.8k |
| NEUROPACE INC NPCE | $2.4m0.21% | Reduced -6.9k |
| CIDARA THERAPEUTICS INC COM | $2.4m0.20% | Reduced -135.8k |
| IMMATICS N.V IMTXW | $2.1m0.18% | Unchanged |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $2.1m0.18% | Reduced -108.8k |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $2.0m0.17% | Added +676.7k |
| SHIFT TECHNOLOGIES INC CL A | $1.8m0.16% | Reduced -1.1m |
| SOLENO THERAPEUTICS INC SLNO | $1.7m0.15% | Unchanged |
| ZOVIO INC ZVOI | $1.6m0.14% | Reduced -958.4k |
| 5 01 ACQUISITION CORP COM CL A | $1.6m0.13% | Reduced -5.4k |
| PAYONEER GLOBAL INC PAYO | $1.5m0.13% | Unchanged |
| IDW MEDIA HLDGS INC CL B | $1.4m0.12% | Reduced -65.6k |
| ANGION BIOMEDICA CORP COM | $1.3m0.11% | Reduced -42.2k |
| HYPERFINE INC HYPR | $1.2m0.11% | Reduced -51.5k |
| IMAC HLDGS INC COM | $1.0m0.09% | Reduced -981.7k |
| LAVA THERAPEUTICS NV LVTX | $953.0k0.08% | Reduced -11.2k |
| ALECTOR INC ALEC | $937.0k0.08% | Reduced -2.6k |
| ACER THERAPEUTICS INC OPXA | $934.0k0.08% | Reduced -36.8k |
| IMV INC COM | $933.0k0.08% | Reduced -441.8k |
| HELIOGEN INC COMMON STOCK | $916.0k0.08% | Reduced -209.7k |
| FARADAY FUTRE INTLGT ELCTR I COM | $910.0k0.08% | Unchanged |
| EXAGEN INC XGN | $896.0k0.08% | Reduced -3.1k |
| EARGO INC COM | $774.0k0.07% | New |
| LUCID DIAGNOSTICS INC LUCD | $698.0k0.06% | Reduced -6.4k |
| UNICYCIVE THERAPEUTICS INC COM | $606.0k0.05% | Added +89.0k |
| COGNITION THERAPEUTICS INC CGTX | $407.0k0.04% | Reduced -3.6k |
| IN8BIO INC INAB | $359.0k0.03% | Reduced -204.0k |
| METROMILE INC COM | $298.0k0.03% | Reduced -718.5k |
| TRANSACT TECHNOLOGIES INC TACT | $279.0k0.02% | Reduced -1.3k |
| PERELLA WEINBERG PARTNERS *W EXP 12/31/202 | $264.0k0.02% | Unchanged |
| CUE BIOPHARMA INC COM | $250.0k0.02% | Reduced -2.1m |
| WEJO GROUP LIMITED WEJOF | $158.0k0.01% | Reduced -82.2k |
| SITIO ROYALTIES CORP *W EXP 08/23/202 | $93.0k0.01% | New |
| B RILEY PRINCIPAL 150 MERGER *W EXP 03/01/202 | $69.0k0.01% | Added +65.0k |
| METROMILE INC *W EXP 02/09/202 | $57.0k0.00% | Unchanged |
| TC BIOPHARM HOLDINGS PLC TCBWF | $56.0k0.00% | Unchanged |
| FTAC HERA ACQUISITION CORP *W EXP 02/28/202 | $53.0k0.00% | Unchanged |
| FINTECH ACQUISITION CORP VI *W EXP 03/31/202 | $39.0k0.00% | Reduced -9.4k |
| RAFAEL HLDGS INC RFL | $36.0k0.00% | New |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| INTERNATIONAL MNY EXPRESS IN IMXI | $29.4m1.4m shares |
| FINTECH ACQUISITION CORP VI | $9.8m1,000.0k shares |
| FINTECH ACQUISITION CORP V | $9.5m958.1k shares |
| HCA HEALTHCARE INC HCA | $8.9m35.6k shares |
| WAYFAIR INC W | $3.8m34.7k shares |
| WAVE LIFE SCIENCES LTD 96663EUR | $1.6m819.1k shares |
| TANGO THERAPEUTICS INC TNGX | $749.0k98.8k shares |
| ELOXX PHARMACEUTICALS INC | $434.0k774.8k shares |
| GALMED PHARMACEUTICALS LTD | $412.0k259.0k shares |
| HTG MOLECULAR DIAGNOSTICS IN | $397.0k286.0k shares |
| FALCON MINERALS CORP | $256.0k674.6k shares |
| OCUGEN INC OCGN | $55.0k16.6k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ISHARES TR IWM · Put | $423.4m2.5m shares | Reduced |
| ELI LILLY & CO LLY · Put | $113.5m350.0k shares | New |
| COSTCO WHSL CORP NEW COST · Put | $47.9m100.0k shares | New |
| IMAX CORP IMAX · Call | $37.0m2.2m shares | Unchanged |
| TRAVEL PLUS LEISURE CO TNL · Call | $35.7m919.1k shares | Unchanged |
| AMPHASTAR PHARMACEUTICALS IN AMPH · Put | $34.8m1.0m shares | Unchanged |
| ADTALEM GLOBAL ED INC CVSA · Put | $32.4m900.0k shares | Added |
| STRYKER CORPORATION SYK · Put | $23.9m120.0k shares | Added |
| DARDEN RESTAURANTS INC DRI · Put | $22.6m200.0k shares | Added |
| HERBALIFE NUTRITION LTD HLF · Call | $17.7m867.7k shares | Added |
| UNIQURE NV QURE · Call | $14.9m800.0k shares | Reduced |
| PELOTON INTERACTIVE INC PTON · Call | $10.5m1.1m shares | Added |
| GOGO INC GOGO · Put | $8.1m500.0k shares | New |
| PERDOCEO ED CORP PRDO · Put | $5.9m500.0k shares | New |
| APOLLO ENDOSURGERY INC Call | $5.8m1.6m shares | New |
| KROGER CO KR · Call | $2.4m50.0k shares | New |
| VROOM INC VRM · Call | $1.9m1.5m shares | Unchanged |
| KEROS THERAPEUTICS INC KROS · Call | $1.2m41.9k shares | Unchanged |
| CODEXIS INC CDXS · Call | $523.0k50.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 63.
| Company | Stake |
|---|---|
| XTANT MED HLDGS INC XTNT · 13D · filed 2025-08-05 | 49.1%≈ $28.8m |
| EAGLE PHARMACEUTICALS INC EGRX · 13G · filed 2025-08-14 | 38.1% |
| EVOKE PHARMA INC 13D · filed 2025-02-03 | 16.0% |
| AYTU BIOPHARMA INC AYTU · 13D · filed 2025-06-09 | 14.4%≈ $2.3m |
| RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-10-07 | 14.1%≈ $11.8m |
| TELA BIO INC TELA · 13G · filed 2026-08-14 | 12.9%≈ $4.3m |
| TALPHERA INC TLPH · 13D · filed 2025-04-03 | 11.7%≈ $2.1m |
| ASSERTIO HOLDINGS INC 13G · filed 2026-04-07 | 10.7% |
| UNICYCIVE THERAPEUTICS INC UNCY · 13G · filed 2026-08-14 | 10.0%≈ $13.2m |
| KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-14 | 10.0%≈ $1.3m |
| AZITRA INC AZTR · 13G · filed 2026-08-14 | 10.0%≈ $1.1m |
| FOSSIL GROUP INC FOSL · 13G · filed 2026-05-15 | 10.0%≈ $24.3m |
| FRACTYL HEALTH INC 13G · filed 2026-05-15 | 10.0%≈ $12.8m |
| INSPIREMD INC NSPR · 13G · filed 2026-05-15 | 10.0%≈ $3.4m |
| ENVOY MEDICAL INC COCH · 13G · filed 2026-05-15 | 10.0%≈ $6.1m |
| ABEONA THERAPEUTICS INC ABEO · 13G · filed 2026-05-15 | 10.0%≈ $35.7m |
| CURIS INC 13G · filed 2026-04-24 | 10.0%≈ $2.2m |
| APYX MEDICAL CORPORATION APYX · 13G · filed 2026-02-13 | 10.0%≈ $18.5m |
| DARIOHEALTH CORP DRIO · 13G · filed 2026-02-13 | 10.0%≈ $4.5m |
| ELUTIA INC ELUT · 13G · filed 2026-02-13 | 10.0%≈ $4.0m |
| UNICYCIVE THERAPEUTICS INC 13G · filed 2025-11-14 | 10.0% |
| DARIOHEALTH CORP DRIO · 13G · filed 2025-08-14 | 10.0% |
| BIOMX INC 13G · filed 2025-05-15 | 10.0% |
| OPTINOSE INC 13G · filed 2024-11-14 | 10.0% |
| ELOXX PHARMACEUTICALS INC ELOX · 13G · filed 2026-08-14 | 9.9%≈ $5.6m |